Filing Details

Accession Number:
0001179110-13-013098
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-13 17:37:40
Reporting Period:
2013-08-09
Filing Date:
2013-08-13
Accepted Time:
2013-08-13 17:37:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884629 Actavis Inc. ACT Pharmaceutical Preparations (2834) 953872914
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1161920 R Ronald Taylor 138 West Canoe Point Road
Coolin ID 83821
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0033 Acquisiton 2013-08-09 5,000 $29.03 32,942 No 4 M Direct
Common Stock, Par Value $0.0033 Disposition 2013-08-09 5,000 $135.14 27,942 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0033 Non-Qualififed Options to Purchase Common Stock Disposition 2013-08-09 5,000 $0.00 5,000 $29.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2007-05-05 2016-05-05 No 4 M Direct
Footnotes
  1. The price reported on Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from 135.14 to 135.17, inclusive. The reporting person undertakes to provde Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in footnote (1) to this Form 4.
  2. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended.